Established In 2017Taizhou Dachen Pharmaceutical Was Designed And Built To Meet Gmp Guidelinesintegrating Research Development And Production Of Apis And Intermediatesit Was Acquired By Sunrisegroup In 2022I Oewith A Total Annual Output Valueof Approximately 400 Million Yuan Products Trifluoro Methyl1 2 4 Triazole4 A Piperazinehydrochloridepyrazolealoeemodin S 4 2 Chloro 5 Iodophenyl Methyl Phenoxy Tetrahydro Furan R 4S 5R 6R 4 5 Tris Trimethylsilyloxy6 Trimethylsilyloxy Methyl Tetrahydro 2H Pyran 2 Onesodium Hyaluronaten5 R Acetylthio1 Carboxymethyl Amino1 Oxopropan 2 Yll Glutamineetc As Thenational High Tech Enterprisethecompany S Key Products Arepredominantly Demanded In Europesoutheast Asiasouth Americaetc
